Cardiovascular Therapeutics

Scope & Guideline

Advancing Cardiovascular Care Through Open Access Research

Introduction

Immerse yourself in the scholarly insights of Cardiovascular Therapeutics with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1755-5914
PublisherWILEY-HINDAWI
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2008 to 2024
AbbreviationCARDIOVASC THER / Cardiovasc. Ther.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON WIT 5HE, ENGLAND

Aims and Scopes

Cardiovascular Therapeutics aims to advance the field of cardiovascular medicine through innovative research, clinical trials, and therapeutic advancements. The journal focuses on a wide range of topics related to cardiovascular diseases, therapies, and health outcomes, providing a platform for researchers and clinicians to share their findings.
  1. Cardiovascular Risk Assessment and Management:
    The journal publishes studies focusing on the assessment of cardiovascular risk factors, including novel biomarkers and risk prediction models, to enhance the management and prevention of cardiovascular diseases.
  2. Therapeutic Interventions and Clinical Trials:
    A significant emphasis is placed on clinical trials evaluating the efficacy and safety of new therapeutic interventions, including pharmacological treatments, surgical procedures, and lifestyle modifications.
  3. Pathophysiology and Mechanistic Insights:
    Research articles delve into the underlying mechanisms of cardiovascular diseases, exploring cellular and molecular pathways that contribute to conditions such as myocardial infarction, heart failure, and atherosclerosis.
  4. Rehabilitation and Exercise Therapy:
    The journal highlights studies that assess the role of rehabilitation strategies, including exercise therapy and lifestyle interventions, in improving outcomes for patients with cardiovascular conditions.
  5. Emerging Therapies and Natural Products:
    There is a growing interest in the exploration of natural products and alternative therapies for cardiovascular diseases, with studies investigating their potential therapeutic roles and mechanisms of action.
  6. Public Health and Epidemiological Studies:
    Cardiovascular Therapeutics also prioritizes research addressing public health aspects, epidemiological trends, and the socioeconomic impact of cardiovascular diseases.
Recent publications in Cardiovascular Therapeutics have highlighted several trending and emerging themes that reflect the evolving landscape of cardiovascular research. These themes are gaining traction and may represent future directions for the field.
  1. Biomarkers for Cardiovascular Diseases:
    An increasing number of studies focus on identifying and validating novel biomarkers for cardiovascular diseases, particularly in heart failure and atherosclerosis, which can enhance early diagnosis and treatment.
  2. Impact of COVID-19 on Cardiovascular Health:
    Research examining the implications of COVID-19 on cardiovascular health, including the effects of viral infections on existing cardiovascular conditions, has surged, showcasing the pandemic's influence on cardiovascular research.
  3. Integrative and Holistic Approaches to Treatment:
    Emerging interest in integrative therapies, such as meditation, yoga, and lifestyle modifications, reflects a trend towards holistic approaches to cardiovascular health, emphasizing the importance of mental and physical well-being.
  4. Advanced Imaging Techniques and Diagnostics:
    There is a notable trend towards the utilization of advanced imaging techniques for better diagnosis and management of cardiovascular diseases, facilitating more precise interventions.
  5. Artificial Intelligence and Machine Learning in Cardiovascular Research:
    The application of AI and machine learning methods in cardiovascular research is rapidly growing, particularly in risk prediction models and personalized treatment strategies, marking a significant technological advancement in the field.

Declining or Waning

While the journal continues to explore a wide array of cardiovascular topics, certain themes appear to be declining in prominence. This may reflect shifts in research focus or advancements in understanding that have led to reduced interest in specific areas.
  1. Traditional Risk Factor Studies:
    Research focusing solely on traditional cardiovascular risk factors, such as hypertension and hyperlipidemia, has decreased as newer methodologies and biomarkers gain traction in risk assessment.
  2. Pharmacogenomics in Cardiovascular Therapy:
    There has been a waning interest in studies solely dedicated to pharmacogenomic profiling for cardiovascular drug responses, possibly due to advancements in personalized medicine that integrate broader genetic and environmental factors.
  3. Basic Science Studies without Clinical Relevance:
    The journal has seen fewer submissions of basic science studies that do not translate into clinical applications, indicating a preference for research with direct implications for patient care.

Similar Journals

COR ET VASA

Advancing cardiovascular knowledge since 1961.
Publisher: CZECH SOC CARDIOLOGY & CZECH SOC CARDIOVASCULAR SURGERYISSN: 0010-8650Frequency: 6 issues/year

COR ET VASA is a prominent peer-reviewed journal in the field of cardiology and cardiovascular medicine, published by the Czech Society of Cardiology and Czech Society of Cardiovascular Surgery. Established in 1961, and continuing its legacy from 2006 to 2024, this journal serves as an essential platform for disseminating significant research findings, clinical studies, and innovative treatments in cardiovascular health. While currently positioned in the Q4 quartile, the journal aims to enhance its impact by fostering knowledge sharing among researchers, clinicians, and students alike. The journal, with its publication in Czech Republic, provides a unique perspective to the European cardiovascular community, allowing for invaluable insights and discourse. Researchers are encouraged to submit their manuscripts and contribute to the growing body of knowledge in this critical area, although it should be noted that COR ET VASA does not offer open access options at this time. As the field of cardiovascular medicine evolves, COR ET VASA remains committed to addressing the latest challenges and advancements, nurturing a rich dialogue within the community.

Arquivos Brasileiros de Cardiologia

Unveiling new horizons in cardiology through open access.
Publisher: ARQUIVOS BRASILEIROS CARDIOLOGIAISSN: 0066-782XFrequency: 12 issues/year

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

HEART AND VESSELS

Exploring Innovations in Cardiology and Vascular Medicine
Publisher: SPRINGERISSN: 0910-8327Frequency: 12 issues/year

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology

Empowering cardiology through open access and collaboration.
Publisher: KARE PUBLISSN: 1016-5169Frequency: 8 issues/year

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology is a prominent peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine. Published by KARE PUBL, this journal has established itself as a key resource for researchers, healthcare professionals, and students since its inception in 1990. As an Open Access journal since 2017, it ensures that cutting-edge research and clinical findings are readily accessible to a global audience, thus fostering collaboration and knowledge sharing among the cardiology community. With its recent rank in the Q3 quartile for Cardiology and Cardiovascular Medicine in 2023, and a Scopus rank of #282 out of 387, the journal is positioned to enhance its influence in the cardiovascular field, offering valuable insights and promoting evidence-based practices. The journal covers a wide range of topics within cardiology and cardiovascular research, making it an essential platform for scholars aiming to contribute to the ongoing dialogue in this vital area of medicine. For those eager to stay updated with the latest research trends and clinical practices in cardiology, Turk Kardiyoloji Dernegi Arsivi represents a crucial resource.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Fostering Collaboration for Global Cardiovascular Health
Publisher: ELSEVIER SCIENCE INCISSN: 0735-1097Frequency: 50 issues/year

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, the esteemed publication of Elsevier Science Inc, stands as a premier platform for advancing knowledge in the field of cardiology and cardiovascular medicine. With an impressive impact factor reflecting its prominence—ranked Q1 in its category for 2023 and occupying the 4th position out of 387 in the Scopus listings, firmly placing it in the 99th percentile—this journal is essential for researchers, clinicians, and students alike. Since its inception in 1983, it has continuously provided a vital space for high-quality research and innovative clinical practices, driving forward our understanding of cardiovascular health. While access options are not open, the value of the cutting-edge articles published here cannot be overstated, as they foster collaboration and inform better patient care across the globe. As part of its ongoing commitment to excellence, the journal solicits submissions of original research, reviews, and clinical studies that contribute meaningfully to the field and engage its diverse readership.

European Journal of Preventive Cardiology

Transforming the future of heart health through research.
Publisher: OXFORD UNIV PRESSISSN: 2047-4873Frequency: 18 issues/year

The European Journal of Preventive Cardiology, published by Oxford University Press, is a leading international journal dedicated to the field of cardiology and cardiovascular medicine. With an impact factor that underscores its prestige—ranking in the top quartile (Q1) of both cardiology and epidemiology categories—the journal serves as a critical resource for researchers and practitioners seeking to advance their understanding of preventive strategies in cardiovascular health. Since its inception in 1999, it has provided a platform for high-quality research and reviews that address the epidemiology of cardiovascular diseases, risk factor management, and innovative prevention methodologies. Notably, it currently ranks #21 out of 387 in Medicine - Cardiology and #13 out of 148 in Medicine - Epidemiology according to Scopus, highlighting its influential position in these essential biomedical fields. The journal also provides open access options, allowing both readers and authors the opportunity to engage with groundbreaking research and enhance the dissemination of knowledge. With a commitment to excellence, the European Journal of Preventive Cardiology is an invaluable asset for those dedicated to the prevention of cardiovascular diseases.

CARDIOVASCULAR RESEARCH

Elevating knowledge in cardiovascular medicine.
Publisher: OXFORD UNIV PRESSISSN: 0008-6363Frequency: 18 issues/year

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

CURRENT CARDIOLOGY REVIEWS

Pioneering Insights for Today's Cardiologists
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-403XFrequency: 4 issues/year

CURRENT CARDIOLOGY REVIEWS, an esteemed journal published by BENTHAM SCIENCE PUBL LTD, is a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1573-403X and E-ISSN of 1875-6557, this journal presents comprehensive reviews that contribute significantly to the advancement of scientific knowledge and clinical practices in cardiology. Operating with open access options, CURRENT CARDIOLOGY REVIEWS is dedicated to bridging the gap between research and practice, thereby encouraging interdisciplinary collaboration and knowledge sharing. The journal has been instrumental in disseminating high-impact findings, consistently maintaining a Q2 category ranking in both Cardiology and Cardiovascular Medicine, as well as within the miscellaneous categories of Medicine, highlighting its relevance and respect in the academic community. Researchers, practitioners, and students alike will find valuable insights into contemporary cardiovascular issues, practices, and innovations that promote better patient outcomes. Based in the United Arab Emirates, CURRENT CARDIOLOGY REVIEWS encourages global contributions and reflects the latest advancements up to the year 2024, solidifying its role as an essential publication for those engaged in the quest for excellence in cardiovascular health.

AMERICAN HEART JOURNAL

Transforming Cardiovascular Care with Cutting-Edge Studies
Publisher: MOSBY-ELSEVIERISSN: 0002-8703Frequency: 12 issues/year

AMERICAN HEART JOURNAL, published by MOSBY-ELSEVIER, stands at the forefront of cardiovascular research, encompassing a vast array of studies focused on heart health, cardiology, and related medical therapies. Established in 1925 and set to continue its legacy into 2024, this esteemed journal holds a prestigious Q1 ranking in the category of Cardiology and Cardiovascular Medicine, reflecting its commitment to quality and significant influence in the field, as evidenced by its 85th percentile ranking in Scopus. With a dedicated readership of researchers, clinicians, and students, the journal serves as a critical platform for sharing groundbreaking findings, innovative techniques, and comprehensive reviews that strive to advance cardiovascular science. Although it does not currently offer open access, the AMERICAN HEART JOURNAL remains an indispensable resource for anyone invested in the evolution and improvement of heart health.

Frontiers in Cardiovascular Medicine

Elevating Cardiovascular Research Through Open Access.
Publisher: FRONTIERS MEDIA SAISSN: 2297-055XFrequency: 1 issue/year

Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.